From: Neoadjuvant chemotherapy versus primary surgery in advanced ovarian carcinoma
 | Conventional Group (n = 32) | NACT Group (n = 18) | p value |
---|---|---|---|
Duration of surgery | Â | Â | Â |
   Mean | 190 | 150 | NS |
   range | 70–350 | 90–270 |  |
Blood loss rates (cc) | Â | Â | Â |
   Mean | 735 | 420 | 0.02 |
   Range | 50–5000 | 50–3000 |  |
ICU stay (days) | Â | Â | Â |
   Mean | 4.4 | 1.7 | 0.03 |
   Range | 1–9 | 1–5 |  |
Hospital stay (days) | Â | Â | Â |
   Mean | 15.9 | 10.5 | 0.05 |
   Range | 6–49 | 4–31 |  |
Wound infection | 2 | 2 | NS |
Fever > 38.5°C > 3 d | 7 | 1 | NS |
Atelectasis | 1 | 1 | NS |
Pleural effusion | 2 | 0 | NS |
DVT | 3 | 1 | NS |